BIBLIOGRAPHY

Adams, J. H., Sim, B. K. L., Dola, L. A., Fang, X. D., Kaslow, D. C., and Miller, L. H. (1992). A family of erythrocyte binding proteins of malaria parasites. Proc. Nat/. Acad. Sci. USA 89, 7085-7089.

Agrawal, A, Kumar, S., Jaffe, R, et al. (1991). Oral Salmonella: Malaria circumsporozoite recombinants induce specific CD8+ cytotoxic T cells. J. Exp. Med 172, 1083-1089.

Aidoo, M., Lalvani, A, Allsopp, C. E. M., Plebanski, M., Meisner, S. J., Krausa, P., Browning, M., Morris-Jones, S., Gotch, F., Fidock, D. A., Takiguchi, M., Robson, K. J. H, Greenwood, B. M., Druilhe, P., Whittle, H. C., and Hill, A. V. S. (1995). Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria. Lancet 345, 1003-1007.

Aikawa, M., Miller, L. H, Rabbeje, J., and Epstein, N. (1981). Freeze fracture study on erythrocyte membrane during malaria parasite invasion. J. Cell. Bioi. 91, 55-62.

Aitken, A., and Learmonth. Carboxymethylation of cysteine using iodoacetamide/iodoacetic acid, p. 339-340. In Protein Protocols Handbook. Walker, J. M. (ed). Humana Press Inc., Totowa, NJ.

AI-Yaman, F., Genton, B., Anders, R., Taraika, J., Ginny, M., Mellor, S., and Alpers, M. P. (1995a). Assessment of the role of the humoral response to Plasmodium falciparum MSP 2 compared to RESA and SPf66 in protecting Papua New Guinea children from clinical malaria. Parasite Immunol. 17, 493-501.

Al-Yaman, F., Genton, B., Kramer, K. J., Taraika, J., Chang, S. P., Hui, G. S., and Alpers, M. P. (1995b). Acquired antibody levels to Plasmodium falciparum merozoite surface antigen 1 in residents of a highly endemic area of Papua New Guinea. Trans. R Soc. Trap. Med Hyg. 89, 555-559.

Al-Yaman, F.B., Genton, B., Kramer, K.J., Chang, S.P., Hui, G.S.N., Baisor, M., and Alpers, M.P. ·(1996). Assessment of the role of naturally acquired antibody levels of Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinea children from malaria morbidity. Am. J. Trap. Med Hyg. 54, 443-448.

Amador, R, Moreno, A., Valero, V., Murillo, L. A., Mora, A., Rojas, M., Rocha, C., Salcedo, M., Guzman, F., Espejo, F., Nunez, F., and Patarroyo, M. E. (1992). The first field trials of the chemically synthesised malaria vaccine Spf66: safety, immunogenicity and protectivity. Vaccine. 10, 179-184.

Anders, R. F. (1986). Multiple cross react1v1ties amongst antigens of Plasmodium falciparum impair the development of protective immunity against malaria. Parasite Immuno/. 8, 529-539.

Argraves, W. S., Deak, F., Sparks, K. J., Kiss, I., and Goetinck, P. F. (1987). Structural features of cartilage matrix protein deduced from eDNA. Proc. Nat/. Acad Sci. USA. 84, 464-468.

Asch, A. S., Heimer, E., and Nachman, R. L. (1990). An amino acid sequence motif in thrombospondin is responsible for CD36 binding. Blood76 (suppl 1), 445a.

Atkinson, C. T., Hollingdale, M. R, and Aikawa, M. (1992). Localization of a 230 kD parasitophorous vacuole membrane antigen of Plasmodium berghei exoerythrocytic schizonts (LSA-2) by immunoelectron and confocal laser scanning microscopy. Am. J. Trap. Med Hyg. 46, 533-537.

Bale, M.D., Westrick, L. G., and Mosher, D. F. (1985). Incorporation of thrombospondin into fibrin clots. J. Bioi. Chem. 260, 7502-7508.

Ballou, W. R., Hoffman, S. L., Sherwood, J. A., Hollingdale, M. R., Neva, F. A., Hockmeyer, W. T., Gordon, D. M., Schneider, I., Wirtz, R. A., Young, J. F., eta!. (1987). Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccme. Lancet I, 1277-1281.

Bannister, L.H, Butcher, B. A., and Mitchell, G. H. ((1977). Recent advances in understanding the invasion of erythrocytes by merozoites of Plasmodium knowlesi. Bull. WHO 55, 163-169.

Barr, P. J., Green, K. M., Gibson, H. L., eta!. (1991). Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals. J. Exp. Med 174, 1203-1208.

Baruch, D. 1., Pasloske, B. L., Singh, S. B., Bi, X., Ma, X. C., Feldman, M., Taraschi, T. F., and Howard, R. J. (1995). Cloning of the P. Jalciparum gene encoding PfEMPl, a malaria variant antigen and adherence receptor on the surface of parasitized human erythrocytes. Cell82, 77-87.

Bastianelli, G. and Bignami, A. ( 1899). Sullo sviluppo dei parassiti della terzana nell' Anopheles claviger. Atti. Soc. Studi. Malar. 1, 28-49.

Beadle, C., McElroy, C. P., Oster, N.C., Beier, J. C., Oloo, A. J., Onyango, F. K., Chumo, D. K., Bales, J. D., Sherwood, J. A., and Hoffman, S. L. (1995). Infection of transmission intensity and age on Plasmodium falciparum density and associated fever: implications for malaria vaccine design. J.lnfect. Dis. 172, 1047-1054.

Bentley, D. R. (1986). Primary structure of human complement component C2. Homology to two unrelated protein families. Biochem. J. 239, 339-245.

Berke, G. (1995). TheCTL'skiss ofdeath. Cell81, 9-12.

Blackman, M. J., Heidrich, H. G., Donachie, S., McBride, J. S., and Holder, A. A. (1990). A single fragment of a malaria merozoite surface protein remains on the parasite during cell invasion and is the target of invasion inhibiting antibodies. J. Exp. Med 172, 3 79-3 82.

Blackman, M. J., Ling, I. T., Nicholls, S. C., and Holder, A. A. (1991). Proteolytic processing of the Plasmodium falciparum merozoite surface antigen-! produces a membrane bound fragment containing two epidermal growth factor like domains. Mol. Biochem. Parasitol. 49, 29-34.

Borre, M. B., Dziegiel, M., Hogh, B., Peterson, E., Rieneck, K, Riley, E., Meis, J. F., Aikawa, M., Nakamura, K., Harada, M., Wind, A., Jakobson, P. H., Cowland, J., Jepsen, S., Axelsen, N. H, and Vuust, J. (1991). Primary structure and localization of a consetved Plasmodium jalciparum glutamate rich protein (GLURP) expressed in both the preerythrocytic and erythrocytic stages of the vertebrate life cycle. Mol. Biochem. Parasitol. 49, 119-132.

Bouharoun-Tayoun, H, Attanath, P., Sabchareon, A, Chongsuphajaisiddhi, T., and Druilhe, P. (1990). Antibodies that protect humans against Plasmodium falciparum blood stage do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J Exp. Med 172, 1633-1641.

Boyd, M. F. (1949). "Malariology". Saunders, Philadelphia, Pennsylvania.

Brabin, B. J. (1985). Epidemiology of infection in pregnancy. Rev. Infect. Dis. 7, 579-603.

Bradham, D. M., Igarashi, A., Potter, R. L., and Grotendorst, G. R. (1991). Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell. Bioi. 114, 1285-1294.

Breasted, J. H. (1930). "Edwin Smith Surgical Papyrus". Uni. of Chicago Press, Chicago, lllinois.

Bums, J., M., J., Parke, L. A, Daly, T. M., et al. (1989). A protective monoclonal antibody recognizes a variant specific epitope in the precursor of the major merozoite antigen of the rodent malaria parasite Plasmodium yoelii. J Immunol. 142, 2835-2840.

Bushell, G. R, Ingram, L. T., Fardoulys, C. A., and Copper, J. A. (1988). An antigenic complex in the rhoptries of Plasmodiumfalciparum. Mol. Biochem. Parasitol. 28, 105-112.

Butler, D. (1997). Briefing malaria. Nature 386, 10: 535-541.

Cattani, J. and Lengeler, C. (1997). Insecticide-treated bednets and the prevention of malaria. Rec. Adv. Paediatr. 16, in press.

Cerami, C., Frevert, U., Sinnis, P., Takacs, B., Clavijo, P., Santos, M. J., and Nussenzweig, V. (1992). The basolateral domain of the hepatocyte plasma membrane bears receptors for the circumsporozoite protein of Plasmodiumfalciparum sporozoites. Cel/70, 1021-1033.

Chakravarti, D. N., Chakravarti, B., Parra, C. A., and Muller-Eberhard, H. J. (1989). Structural homology of complement protein C6 with other channel-forming proteins of complement Proc. Nat/. Acad. Sci. US A. 86, 2799-803.

Chang, S. P., Case, S. E., Gosnell, W. L., Hashimoto, A, Kramer, K. J., Tam, L. Q., Hashiro, C. Q., Nikaido, C. M., Gibson, H. L., Lee-Ng, C. T., Barr, P. J., Yokoto, B. T., and Hui, G. S. N. (1996). A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria. Inject. Immun. 64, 253-261.

99

Charoenvit, Y., Fallarme, V., Rogers, W. 0., Sacci, J. B. Jr., Kaur, M., Aguiar, J. C., Yuan, L. F., Corradin, G., Andersen, E., Wizel, B., Houghten, R. A., Oloo, A., DelaVega, P., and Hoffman, S. L. (1997). Development of two monoclonal antibodies against Plasmodium falciparum sporozoite surface protein 2 and mapping ofB-cell epitopes. Infect. Immun. 65, 3430-3437.

Charoenvit, Y., Leef, M. F., Yuan, L. F., Sedegah, M., and Beaudoin, R. L. (1987). Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigens. Infect. Immun. 55, 604-608.

Charoenvit, Y., Mellouk, S., Sedegah, M., Toyoshima, T., Leef, M. F., De la Vega, P., Beaudoin, R. L., Aikawa, M., Fallarme, V., and Hoffman, S. L. (1995). Plasmodium yoelii: 17-kDa hepatic and erythrocytic stage protein is the target of an inhibitory monoclonal antibody. Exp. Parasitol. 80, 419-429.

Chin, W., Contacos, P. G., Coatney, G. R. and Kimball, H. R. (1965). A naturally acquired quotidian-type malaria in man transferable to monkeys. Science 149, 865.

Chitnis, C. E., and Miller, L. H. (1994). Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion. J. Exp. Med 180, 497-506.

Chu, M. L., Pan, T. C, Conway, D., Kuo, H. J., Glanville, R. W., Timpl, R., Mann, K., and Deutzmann, R. (1989). Sequence analysis of alpha 1(VI) and alpha 2(VI) chains of human type VI collagen reveals internal triplication of globular domains similar to the A domains of von Willebrand factor and two alpha 2(VI) chain variants that differ in the carboxy terminus. EMBOJ. 8, 1939-1946.

Clark, I. A. and Rockett, K. A. (1994). The cytokine theory of human cerebral malaria. Parasitol. Today 10, 410-411.

Clark, J. T., Donachie, S., Anand, R., Wilson, C. F., Heidrich, H. G., and McBride, S. (1988). 46-53 kDa glycoprotein from the surface of Plasmodium falciparum merozoites. Mol. Biochem. Parasitol. 32, 15-24.

Clarke, L. E., Tomley, F. M., Wisher, M. H., Foulds, I. J., and Boursnell, M. E. (1990) Regions of an Eimeria tenella antigen contain sequences which are conserved in circumsporozoite proteins from Plasmodium sp. and which are related to the thrombospondin gene family. Mol. Biochem. Parasitol. 41, 269-79.

Clyde, D. F., McCarthy, V. C., Miller, R. M., and Hornick, R. B. (1973a). Specificity of protection of man immunized against sporozoite-induced falciparum malaria. Am. J. Med. Sci. 266, 398-403.

Clyde, D. F., McCarthy, V. C., Miller, R. M., and Woodward, W. E. (1975). Immunization of man againstfalciparum and vivax malaria by use of attenuated sporozoites. Am. J. Trop. Med. Hyg. 24, 397-401.

100

Clyde, D. F., Most, H., McCarthy, V. C, et al. (1973b). Immunization of man against sporozoite inducedfalciparum malaria. Am. J Med. Sci. 266, 169-177.

Coatney, G. R. (1971 ). The simian malarias: Zoonoses, anthroponoses, or both? Am. J Trap. Med Hyg. 20, 795-803.

Cohen, S., and Butcher, G. A. (1971). Serum antibody in acquired malarial immunity. Trans. R Soc. Trap. Med Hyg. 65, 125.

Cohen, S., McGregor, I. A., and Carrington, S. (1961 ). Gamma-globulin and acquired immunity to human malaria. Nature 192,733-737.

Collins, W. E., Pye, D., Crewther, P. E., Vandenberg, K. L., Galland, G. G., Sulzer, A. J., Kemp, D. J., Edward, S. J., Coppel, R. L., Sullivan, J. S., Morris, C. L., and Anders, R. F. (1994). Protective immunity induced in squirrel monkeys with recombinant apical membrane antigen- I of Plasmodiumfragili. Am. J Trap. Med Hyg. 51,711-719.

Colombatti, A., Bonaldo, P., and Doliana, R. (1993). Type A modules: interacting domains found in several non-fibrillar collagens and in other extracellular matrix proteins. Matrix 13, 297-306.

Cooper, J. A. (1993). Merozoite Surface Antigen-1 of Plasmodium. Parasitol. Today 9, 50-54.

Corbi, A. L., Kishimoto, T. K., Miller, L. J., and Springer, T. A. (1988). The human leukocyte adhesion glycoprotein Mac-1 (complement receptor type 3, CD11b) alpha. subunit. Cloning, primary structure, and relation to the integrins, von Willebrand fl;lctor and factor B . . f. Bioi. Chem. 263, 12403-12411.

Cowan, G., Krishna, S., and Robson, K. (1992). Expression of thrombospondin-related anonymous protein in Plasmodiumfalciparum sporozoites. Lancet 339, 1412.

Cowman, A. F., Coppel, R. L., Saint, R. B., et al. (1984). Ring infected erythrocyte surface antigen (RESA) polypeptide of P. falciparum contains two separate blocks of tandem repeats encoded antigenic epitopes that are naturally immunogenic in man. Mol. Bioi. Med 2, 207-221.

Creighton, T. E. (1993). Proteins: Structures and Molecular Properties. 2nd Ed. Freeman, New York.

Crewther, P. E, Culvenor, J. G., Silva, A., Cooper, J. A., and Anders, R. F. (1990). Plasmodium falciparum - 2 antigens of similar size are located in different compartments of the rhoptry. Exp. Parasitol. 70, 193-206.

Crewther, P. E., Matthew, M. L. S.M., Flegg, R. H., and Anders, R. F. (1996). Protective immune responses to apical membrane antigen 1 of Plasmodium chabaudi involve recognition of strain-specific epitopes. Infect. Immun. 64, 3310-3317.

D' Alessandro, U., Ceach, A., Drakeley, C. J., et al. (1995). Efficacy trial of malaria vaccine SPf66 in Gambian infants. Lancet 346, 462-467.

101

David, P. H. et al. (1988). Am. J. Trap. Med. Hyg. 38, 289-297.

Davison, B. B., Cogswell, F. B., Baskin, G. B., Falkenstein, K. P., Henson, E. W., Tarantal, A. F., and Krogstad, D. J. (1998). Plasmodium coatneyi in the rhesus monkey (Macaca mulatta) as a model of malaria in pregnancy. Am. J. Trap. Med. Hyg. 59, 189-201.

Deans, J. A, Alderson, T., Thomas, A. W., Mitchell, G. H., Lennox, E. S., and Cohen, S. (1982). Rat monoclonal antibodies which inhibit the in vitro multiplication of Plasmodium knowlesi. Clin. Exp. Immunol. 49, 297-309.

Deans, J. A., Knight, A. M., Jean, W. C., Waters, A. P., Cohen, S., and Mitchell, G. H. (1988). Vaccination trials in rhesus monkeys with a minor, invariant Plasmodium knowlesi 66 kDa antigen. Parasite Immunol. 10, 535-552.

Debrabant, A, Maes, P., Delplace, P., Dubermetz, F., Tartar, A., and Camus. D. (1992). Intermolecular mapping of Plasmodium falciparum p126 proteolytic fragments by N­terminal amino acid sequencing. Mol. Biochem. Parasitol. 53, 89-95.

Delplace, P. B., Fortier, G., Tronchin, J., Dubermetz, F., and Vemes, A. (1987). Localization, biosynthesis, processing, and isolation of a major 126 kDa antigen of the parasitophorous vacuole of Plasmodiumfalciparum. Mol. Biochem. Parasitol. 23, 193-201.

Delportillo, H.A.S., Longacre, S., Khouri, E., and David, P.H. 1991. Primary structure of the merozoite surface antigen -1 of Plasmodium vivax reveals sequences conserved between different Plasmodium species. Proc. Nat. Acad. Sci. USA 88, 4030-4034.

Diamond, M. S., Garcia-Aguilar, J., Bickford, J. K., Corbi, A. L., and Springer, T. A. (1993). The 1-domain is a major recognition site on the leukocyte integrin Mac-1 (CD 11 b/CD 18) for four distinct adhesion ligands. J. Cell Bioi. 120, 1031-1043.

Doolan, D. L., et al. (1996). Circumventing genetic restriction of protection against malaria with multigene immunization: cos+ cell-, interferon-, and nitric oxide-dependent immunity. J. Exp. Med. 183, 1739-1746.

Doolan, D. L, et al. (1997). Degenerate cytotoxic T cell epitopes from Plasmodium falciparum restricted by multiple lll.,A-A and lll.,A-B supertype alleles. Immunity 7, 97-112.

Doolan, D. L., Saul, A. J., and Good, M. F. (1992). Geographically restricted heterogeneity of P. falciparum CSP: Relevance for vaccine development. Infect. Immun. 60, 675-682.

Druilhe, P., and Perignon, J. L. (1994). Mechanisms of defense against P. falciparum asexual blood stages in humans.Immunol. Lett. 41, 115-120.

Dubois, P., and Pereira da Silva, L. (1995). Towards a vaccine against asexual blood stage infection by Plasmodiumfalciparum. Res.Immunol. 146, 263-275.

102

Duffy, P. E., Pimenta, P., and Kaslow, D. C. (1993). Pgs28 belongs to a family of epidennal growth factor-like antigens that are targets of malaria transmission blocking antibodies. J. Exp. Med 177, 505-510.

Dustin, M. L. eta/. (1986). J. Immunol. 137,245-254.

Dutta, S., Malhotra, P. and Chauhan, V. S. (1995). Sequence analysis of apical membrane antigen (AMA-1) of P. cynomolgi bastianelli. Mol. Biochem. Parasitol. 73, 267-270.

Edelman, R, Hoffman, S. L., Davis, J. R, Beier, M., Sztein, M. B., Losonsky, G.,Herrington, D. A., Eddy, H. A., Hollingdale, M. R., Gordon, D. M., and Clyde, D. F. (1993). Long term persistence of sterile immunity in a volunteer immunized with X­irradiated Plasmodiumfalciparum sporozoites. J. Infect. Dis. 168, 1066-1070.

Egan, A.E., Morris, J., Barnish, G., Alln, S., Greenwood, B.M., Kaslow, D.C., Holder, A.A., and Riley, E.M. 1996. Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19 kDa C-terminal fragment of the merozoite surface antigen PfMSP-1. J. Infect. Dis. 173,765-769.

Egan, J. E., Hoffman, S. L., Haynes, J. D., Sadoff, J. C., Schneider, 1., Grau, G. E., Hollingdale, M. R, Ballou, W. R, and Gordon, D. M. (1993). Humoral immune responses in volunteers immunized with irradiated Plasmodium falciparum sporozoites. Am. J. Trap. Med. Hyg. 49, 166-173.

Egan, J. E/, Weber, J. L., Balloum W. R., Hollingdalem M. R., Majarianm W. R., Gordonm D. M., Maloym W. L., Hoffmanm, S. L., Wirtzm R. A., Schneider, 1., et al. (1987). Efficacy of murine malaria sporozoite vaccines: implications for human vaccine development. Science 236, 453-456.

Epping, R. J., Goldstone, S.D., Ingram, L. T., Upcroft, J. A., Ramasamy, R, Cooper, J. A., Bushell, G. R, and Geysen, H. M. (1988). An epitope recognized by inhibitory monoclonal antibodies that react with a 51 kilodalton merozoite surface antigen in Plasmodiumfalciparum. Mol. Biochem. Parasitol. 28, 1-10.

Escalante, A. A., and Ayala, F. J. (1994). Phylogeny of the malarial genus Plasmodium, derived from rRNA gene sequences. Proc. Nat/. Acad. Sci. USA 91, 11373-11377.

Edinger, H. M., Caspers, P., Matile, H., Schonfeld, H. J., Stuber, D., and Takacs, B. (1991 ). Ability of recombinant or native proteins to protect monkeys against heterologous challenge with Plasmodiumfalciparum. Infect. Jmmun. 59, 3498-3503.

Fang, X. D., Kaslow, D. C., Adams, J. H., and Miller, L. H. (1991). Cloning of Plasmodium vivax Duffy receptor. Mol. Biochem. Parasitol. 44, 125-132.

Fenton, B., Clark, J. T., Khan, C. M. A., Robinson, J. V., Walliker, D., Ridley, R, Svaife, J. G., and McBride, J. S. (1991). Structural and antigenic polymorphism of the 35-48-kDa merozoite surface antigen (MSA-2) of the malaria parasite Plasmodium falciparum. Mol. Cell. Bioi. 11, 963-971.

103

Ferreira, A., Schofield, L., Enea, V., et a!. (1986). Inhibition of development of exoerythrocytic forms of malaria parasite by gamma- interferon. Science 232, 881-884.

Fidock, D. A., Gras Masse, H, Lepers, J. P., Brahimi, K., BenMohamed, L.,Melouk, S., Guerin-Marchand, C., Londono, A., Raharimalala, L., Meis, J. F., Langsley, G., Roussilhon, C., Tartar, A., and Druilhe, P. (1994). Plasmodium falciparum liver stage antigen-1 is well conserved and contains potent B and T cell determinants. J. Immunol. 153, 190-204.

Foote, S. J., and Kemp, D. J. (1989). Chromosomes of malaria parasites. Trends Genet. 5, 337-342.

Fox, G., Parry, N. R., Barnett, P. V., McGinn, B., Rowlands, D. J., and Brown, F. (1989). The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid). J. Gen. Viral. 70, 625-37.

Frevert, U., Sinnis, P.,Cerami, C., Shreffler, W., Takacs, B., and Nussenzweig, V. (1993). Malaria circumsporozoite protein binds to heparan sulfate proteoglycans associated with the surface membrane of the hepatocytes. J. Exp. Med. 177, 1287-1298.

Fried, M. and Duffy, P. E. (1996). Adherence of Plasmodium falciparum to chondriotin sulfate A in human placenta. Science 272, 1502.

Fries, H. C., Lamers, M. B., Van Deursen, J., Ponnudurai, T., and Meuwissen, J. H. (1990). Biosynthesis of the 25 kDa protein in the macrogametes/zygotes of Plasmodium falciparum. Exp. Parasitol. 71, 229-235.

Gantt, S. M., Clavijo, P., Bai, X., Esko, J. D., and Sinnis, P. (1997). Cell adhesion to a motif shared by the malaria circumsporozoite protein and thrombospondin is mediated by its glycosaminoglycan-binding region and not by CSVTCG. J. Bioi. Chem. 272, 19205-19213.

Garnham, P. C. C. (1959). New subspecies of P. cynomolgi. Rev. Parasitol. 20, 273-278.

Gamham, P. C. C. (1966). "Malaria Parasites and other Haemosporida". Blackwell, Oxford.

Garnham, P. C. C. (1988). Malaria parasites of man: Life cycle and morphology. pp 62-96. Malaria principles and practice of malariology. Vol. I. W. H. Wemsdorfer and I. McGregor eds. Churchill Livingstone Publications, Edinburgh.

Garraud, 0. Perraut, R, Gysin, J., Behr, C., Dubois, P., Bonnemains, B., Jouin, H., Michel, J. C., and Pereira da Silva, L. (1994). Manipulating blood T cells and B cells from squirrel monkeys: some technical considerations. J. Immunol. Methods 173, 165-173.

Garraud, 0., Blanchard, D., and Perraut, R. (1993). FcyR-expressing monocytes are necessary for PWM-induced proliferation of Saimiri sciureus peripheral blood mononuclear cells. Res. immunol. 144, 129-139.

104

Gibson, H. L., Tucker, J. E., Kaslow, D. C., Krettli, A. U., Collins, W. E., Kiefer, M. C., Bathurst, I. C., and Barr, P. J. (1992). Structure and expression of the gene Pv200, a major blood stage surface antigen of Plasmodium vivax. Mol. Biochem. Parasitol. 50, 325-334.

Gonzalez, C., Hone, D., Noriega, F. R. eta!. (1994). Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: Strain construction and safety and immunogenicity in humans. J. Infect. Dis. 169, 927-931.

Gordon, D. M., McGovern, T. W., Krzych, U., Cohen, J. C., Schneider, l, LcChance, R., Heppener, D. G., Yuan, G., Hollingdale, M., Slaoui, M., Hauser, P., Voet, P., Sadoff, J. C., and Ballou, W. R. (1995). Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine. J. Infect. Dis. 171, 1576-1585.

Goundis, D., and Reid, K. B. M. (1988). Properdin, the terminal complement components, thrombospondin and the circumsporozoite protein of malaria parasites contain similar sequence motifs. Nature 335, 82-85.

Grassi, B. Bignami, A., and Bastianelli, G. (1899a). Cicio ivolutio delle semilune nell' Anopheles claviger. Atti. Soc. Studi Malar. 1, 14.

Grassi, B. Bignami, A., and Bastianelli, G. (1899b). Resoconto degli studi fatti sulla malaria durante il mese di Gennaio. Atti Accad. Naz. Lincei, cl. Sci. Fis., Mat Nat. Rend 8 (5), 100-104. .

Groux, H, and Gysin, J. (1990). Opsonization as an effector machanism in human protection against asexual blood stages of Plasmodium falciparum: functional role of IgG subclasses. Res. Immunol. 141, 529-542.

Grun, J. L., Long, C. A., and Weidanz, W. P. (1985). Effects of splenectomy on antibody­independent immunity to Plasmodium chabaudi adami malaria. Infect. Immun. 48, 853.

Guerin-Marchand, C., Druilhe, P., Galey, B., Londono, A., Patarapotikul, J., Beaudoin, R. L., Debaux, C., Tartar, A., Mercereau Pujalon, 0., and Langsley, G. (1987). A liver-stage­specific antigen of Plasmodiumfalciparum characterized by gene cloning. Nature 329, 164-169.

Gwadz, R. W., Cochrane, A. H., Nussenzweigh, V., and Nussenzweigh, R. S. (1979). Preliminary studies on vaccination of rhesus monkeys with irradiated sporozoites of Plasmodium knowlesi and characterization of surface antigens of these parasites. Bull. WHO. 57 (supp. 1): 165-173.

Halawani, A., and Shawarby, A. A. (1957). Malaria in Egypt. J. Egypt. Med Assoc. 40, 753-792.

Handunnetti, S. M., David, P. H., Perera, K, L., and Mendis, K. N. (1989). Uninfected erythrocytes form "rosettes" around Plasmodium falciparum infected erythrocytes. Am. J. Trap. Med. Hyg. 40, 115-118.

105

Holder, A. A, and Freeman, R. R. (1981). Imunization against blood stage rodent malaria using purified antigens. Nature 294, 361-366.

Holder, A. N., Crewther, P. E., Mathew, M. L. S. M., et al. (1996). The disulfide bond structure of Plasmodium apical membrane antigen- I. J. Bioi. Chern. 271, 29446-29452.

Hollingdale, M. R, Aikawa, M., Atkinson, C. T., Ballou, W. R, Chen, G., Li, J., Meis, J. F., Sina, B., Wright, C., and Zhu, J. (1990). Non-CS pre-erythrocytic protective antigens. Immunol. Lett. 25, 71-76.

Holt, G. D., Pangburn, M. K., and Ginsburg, V. (1990). Properdin binds to sulfatide [Gal(3-S04)beta 1-1 Cer] and has a sequence homology with other proteins that bind sulfated glycoconjugates. J. Bioi. Chern. 265, 2852-2855.

Howard, R. F. (1995). The secretory pathway of Plasmodium falciparum regulates transport ofp821RAP-1 to the rhoptries. Mol. Biochem. Parasitol. 74, 43-54.

Howard, R. F., Jensen, J. B., and Franklin, J. B. (1993). Reactivity profile of human anti-82 kDa protein antibodies generated during natural infection with Plasmodium falciparum. Infect. Immun. 61, 2960-2965.

Huber, M., Cabib, E., and Miller, L. H. (1991). Malaria parasite chitinase and penetration of the mosquito peritrophic membrane. Proc. Nat!. Acad. Sci. 88, 2807-2810.

Hughes, A. L (1991). CSP genes of malaria parasites (Plasmodium sp.): evidence for positive selection in immunogenic regions. Genetics 127, 345-353.

Hughes, M. K., and Hughes, K. L. (1995). Natural selection of Plasmodium surface proteins. Mol. Biochem. Paras ito!. 71, 99-113.

Inselburg, J., Bzik, D. J., Li, W. B., Green, K. M., Kansopon, J., Hahm, B. K., Bathurst, C., Barr, P. J., Rossan, R.N. (1991). Protective immunity induced in Aotus monkeys by recombinant SERA proteins of Plasmodiumfalciparum. Infect. Immun. 59, 1247-1250.

Jarcho, S. (1964). Some observations on diseases in pre-historic North America. Bull. Hist. Med. 38, 1-18.

Jayaraman, K. S. (1997). India plans $200 million attack on malaria. Nature 386, 536.

Jongwutiwes, S., Putaporntip, C., Kanbara, H., and Tanabe, K. (1998). Variation in the thrombospondin-related adhesive protein (TRAP) gene of Plasmodium falciparum from Thai field isolates. Mol. Biochem. Parasitol. 92, 349-353.

Karnik, S. S., Ridge, K. D., Bhattacharya, S., and Khorana, H. G. (1993). Palmitoylation of bovine opsin and its cysteine mutants in COS cells. Proc. Nat!. Acad Sci. US A. 90, 40-44.

Kemp, D. J., Cappel, R. L., and Anders, R. F. (1987). Repetitive genes and proteins of malaria. Ann. Rev. Micribiol. 41, 181-208.

107

Kemp, D. J., Cowman, A. F. and Walliker, D. (1990). Genetic diversity in Plasmodium fa/ciparum. Adv. Parasitol. 29, 75-149.

Khusmith, S., Charoenvit, Y., Kumar, S., Sedegah, M., Beaudoin, R. L., and Hoffman, S.L. (1991 ). Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein. Science 252, 715-718.

Kidwell, M. G. and Ribeiro, J. M. C. (1992). Can transposable elements be used to drive disease refractoriness genes into vector populations. Parasitol. Today 8, 325-329.

Kiss, I., Deak, F., Holloway, R. G. Jr., Delius, H., Mebust, K. A., Frimberger, E., Argraves, W. S., Tsonis, P. A., Winterbottom, N., Goetinck, P. F. (1989). Structure of the gene for cartilage matrix protein, a modular protein of the extracellular matrix. Exon/intron organization, unusual splice sites, and relation to alpha chains of beta 2 integrins, von Willebrand factor, complement factors B and C2, and epidermal growth factor. J Bioi. Chem. 264, 8126-34.

Klar, A., Baldassare, M., and Jessell, T.M. (1992). F-spondin: a gene expressed at high levels in the floor plate encodes a secreted protein that promotes neural cell adhesion and neurite extension. Cel/69, 95-110.

Kocken, C. H., Jansen, J., Kaan, A. M., Beckers, P. J., Ponnudurai, T., Kaslow, D. C., Konings, R.N., and Schoenmakers, J. G. (1993). Cloning and expression of the gene coding for the transmissi·on blocking target antigen Pfs48/45 of Plasmodium falciparum. Mol. Biochem Parasitol. 61, 59-68.

Krogstad, DJ. (1996). Malaria as a reemerging disease. Epidemiol. Rev. 18(1), 77-89.

Krotoski, W. A., Gamham, P. C., Bray, R. S., Krotoski, D. M., Killick Kendrick, R., Draper, C. C., Targett, G. A, and Guy, M. W. (1982). Observations on early and late postsporozoite tissue stages in primate malaria. I. discovery of a new latent form of Plasmodium cynomolgi (the hypnozoite), and failure to detect hepatic forms within the first 24 hours after infection. Am. J. Trap. Med. Hyg. 31, 24-35.

Kwiatkowski, D., Cannon, J. G., Manogue, K. R., Cerami, A., Dinarello, C. A., and Greenwood, B. M. (1989). Tumour necrosis factor production in Falciparum malaria and its association with schizont rupture. Clin. Exp. Immunology 77, 361.

Kwiatowski, D. (1991). Cytokines and anti-disease immunity to malaria. Res. Immunol. 142, 707-712.

Lackritz, E. M., Campbell, C. C., Ruebush, T. K. 2d., Hightower, A. W., Wakube, W., Steketee, R. W., and Were, J. B. (1992). Effect of blood transfusion on survival among children in a Kenyan hospital. Lancet. 340, 524.

Ladda, R., Aikawa, M., and Sprinz, H. (1969). Penetration of erythrocytes by merozoites of mammalian and avian malaria parasites. J Parasitol. 55, 633-644.

Lakshman Perera, K. L. R, Handunnetti, S., Holm, I., Longacre, S., and Mendis, K. (1998). Baculovirus merozoite surface protein 1 C-terminal recombinant antigens are highly

108

protective in a natural primate model for human Plasmodium vivax malaria. Infect. Immun. 66,

Lambros, C., Vanderberg, J. P. (1979). Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol. 65, 418-420.

Lancisi, G. M. (1717). "De noxiis paludum effiuviis corumque remediis." Salvioni, Roma.

Land, K. M., Sherman, I. W., Gysin, J., and crandall, I. E. (1995). Anti-adhesive antibodies and peptides as potential therapeutics for Plasmodium falciparum malaria. Parasitol. Today 11, 1923.

Larson, R. S., Corbi, A. L., Berman, L., and Springer, T. (1989). Primary structure of the leukocyte function-associated molecule-1 alpha subunit: an integrin with an embedded domain defining a protein superfamily. J Cell Bioi. 108, 703-712.

Laveran, A. (1880). Note sur un nouveau parasite trove dans le sang de plusieurs malades atteints de fievre palustre. Bull. Acad. Med Ser. 2, 9: 1235-1236.

Laveran, A. (1884). "Traite des fievres palustres." Doin, Paris.

Lee, J-0., Rieu, P., Arnaout, A.M., and Liddington, R. (1995). Crystal structure of the A­domain from the A-subunit ofintegrin CR3 (CD11b/CD18). Cell80, 631-638.

Lee, S. -H., Crocker, P., and Gordon, S. (1986). Macrophage plasma membrane and secretory properties in murine malaria. Effect of Plasmodium yoelii blood-stage infection macrophages in liver, spleen, and blood. J Exp. Med. Hyg. 163, 54.

Leung-Hagesteijn, C., Spence, A.M., Stern, B. D., Zhou, Y., Su, M.W., Hedgecock, E. M., and Culotti, J. G. (1992). UNC-5, a transmembrane protein with immunoglobulin and thrombospondin type 1 domains, guides cell and pioneer axon migrations in C. elegans. Cell71, 289-299.

Lew, A. M., Langford, C. J., Anders, R. F., et a!. (1989). A protective monoclonal antibody recognizes a linear epitope in the precursor to the major merozoite antigens of Plasmodium chabaudi adami. Proc. Nat!. Acad Sci. USA 86, 3768-3772.

Lewis, A. P. (1989). Cloning and analysis of the gene encoding the 230 kDa merozoite surface antigen of Plasmodium yoelii. Mol. Biochem. Parasitol. 36, 271-282.

Lopez, M. C., Silva, Y., Thomas, M. C., et a!. (1994). Characterization of SPf66(n): A chimeric molecule used as a malaria vaccine. Vaccine 12, 585-591.

Lawler, J., and Haynes, R. 0. (1986). The structure of human thrombospondin, an adhesive glycoprotein with multiple calcium-binding sites and homologies with several different proteins. J. Cell. Bioi. 103, 1635-1648.

Lunel, F., and Druilhe, P. (1989). Effector cells involved in non-specific and antibody­dependent mechanisms directed against Plasmodium falciparum blood stages in vitro. Infect. Immun. 1, 2043-2049.

109

Luzzi, G. A., Warrell, D. A., Barnes, A. J., and Dunbar, E. M. (1992). Treatment of primaquine-resistant Plasmodium vivax malaria. Lancet 340, 310.

Machiafava, E. and Celli, A. (1884). Sulle alterazioni dei globuli rossi nella infezione da malaria e sulla genesi della melanemia. Arch. Clin. /tal. 14, 265-268.

MacPherson, G. G., Warrel, M. J., White, N. J., Looareesuwan, S., ar1d Warrel, D. A. (1985). Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am. J. Pathol. 119, 3 85-401.

Malik, A., Egan, J. E., Houghton, R. A. et al. (1991). Human cytotoxic T lymphocytes against Plasmodium falciparum circumsporozoite protein. Proc. Nat/. Acad Sci. USA 88, 3300-3304.

Manson, P. (1894). On the Nature and significance ofthe creceutic and flagellated bodies in malarial blood. Br. Med. J. 2, 1306-1308.

Marsh, K. (1992). Malaria-A neglected disease? Parasitology 104, S53-S59.

Marshall, V. M., Anthony, R. L., Bangs-Purnomo, M. J., Anders, R. F., and Cappel, R. L. (1994). Allelic variants of Plasmodiumjalciparum merozoite surface antigen 2 (MSA-2) in a geographically restricted area of Irian Jay a. Mol. Biochem. Parasitol. 63, 13-21.

Marshall, V. M., Cappel, R. L., Anders, R. F., and Kemp, D. J. (1992). Two novel alleles within subfamilies of the merozoite surface antigen 2 (MSA-2) of Plasmodium jalciparum. Mol. Biochem. Parasitol. 50, 181-184.

Marshall, V. M., Zhang, L. -X, Anders, R. F., and Cappel, R. L. (1995). Diversity of the vaccine candidate AMA-1 of Plasmodiumfalciparum. Mol. Biochem. Parasitol. 77, 109.

Marshall, V. M., Zhang, L. X, Anders, R. F., and Cappel, R. L. (1996). Diversity of the vaccine candidate AMA-1 of Plasmodiumfalciparum. Mol. Biochem. Parasitol. 77, 281-284.

Marti, T., Rosselet, S. J., Titani, K., and Walsh, K. A. (1987). Identification of disulfide­bridged substructures within human von Willebrand factor. Biochemistry 26, 8099-8109.

Mauss, H., and Mietzsch, L. (1933). Atebrin, ein neues Heilmittel gegen Malaria. Klin. Wochenschr. 12, 1276-1278.

McBride, J. S., and Heidrich, H. G. (1987). Fragments of the polymorphic Mr 185, 000 glycoprotein from the surface of isolated Plasmodium falciparum merozoites from an antigenic complex. Mol. Biochem. Parasitol. 23, 71-84.

McCahan, D., Crowther, J. R., Belsham, G. J., Kitson, J. D., Duchesne, M., Have, P., Meloen, R. H., Morgan, D. 0., and De Simone, F. (1989). Evidence for at least four antigenic sites on type 0 foot-and-mouth disease virus involved in neutralization; identification by single and multiple site monoclonal antibody-resistant mutants. Gen. Viral. 70, 639-45.

110

McColl, D. J., Silva, A, Foley, M., Kun, J. F. J., Favaloro, J. M., Thompson, J. K., Marshall, V. M., Cappel, R. L., Kemp, D. J., and Anders, R. F. (1994). Molecular variation in a novel polymorphic antigen associated with Plasmodium falciparum merozoites. Mol. Biochem. Parasitol. 68, 53-67.

McConkey, G. A., Waters, A. P., and McCutchan, T. F. (1990). The generation of genetic diversity in malaria parasites. Annu. Rev. Aficrobiol. 44, 479-498.

McCutchan, T. F., Kissinger, J. C., touray, M. G., Rogers, M. G., Li. J., Sullivan, M., Braga, E. M., Krettli, A. U., and Miller, L. H. (1996). Comparison of circumsporozoite proteins from avian and mammalian malarias: biological and phylogenetic implications. Proc. Nat!. Acad. Sci. USA 93, 11889-11894.

McGregor, I. A, and Wilson, R. J. M. (1988). Specific immunity: acquired in man. In: Malaria: Principles and Practices of Malariology. Wernsdorfer, W. H. and McGregor, I. A. (eds.). pp. 559-619. Churchil Livingstone.

Meis, J. F., Jap, P. H., Hollingdale, M. R., et al. (1987). Cellular response against exoerythrocytic forms of Plasmodium berghei in rats. Am. J. Trap. Med. Hyg. 37, 506-510.

Michishita, M., Videm, V., and Arnaout. M. A. (1993). A novel divalent cation-binding site in the A-domain of the beta 2 integrin CR3 (CD11b/CD18) is essential for ligand binding. Cell72, 857-867.

Miettinen-Baumann, A, Strych, W., McBride, J., and Heidrich, H. -G. (1988). A 46000 Dalton Plasmodium falciparum merozoite surface glycoprotein not related to the 185000-195000 Dalton schizont precursor molecule. Isolation and characterization. Parasitol. Res. 74,317-323.

Migliorini. P, Betschart, B., and Corradin, G. (1993). Malaria vaccine: Immunization of mice with a synthetic T-cell helper epitope alone leads to protective immunity. Eur. J. Immuno/23, 582-585.

Miller, L. H., and Hoffman, S. L. (1998). Research towards vaccine against malaria. Nat. Med. (suppl). 4, 520-524.

Miller, L. H, Good, M. F., and Milan Genevieve. (1994). Malaria pathogenesis. Science 264, 1878-1883.

Miller, L. H., Roberts, T., Sahabuddin, M., and McCuthan, T. F. (1993). Analysis of sequence diversity of P.jalciparum MSP-1. Mol. Biochem. Parasitol. 59, 1-14.

Miller, L.H., Roberts, T., Shahabuddin, M., and McCutchan, T.F. (1993). Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1 ). Mol.Biochem. Parasitol. 59, 1-14.

Mitchell, G. H. and Bannister, L. H. (1988). Malaria parasite invasion: interactions with the red cell membrane. CRC Crit. Rev. Oneall Hematol. 8, 255-310.

111

Mole, J. E., Anderson, J. K., Davison, E.A., and Woods, D. E. (1984). Complete primary structure for the zymogen of human complement factor B. J. Bioi. Chern. 259, 3407-3412.

Moreno, A, Clavijo, P., Edelman, R., et al. (1991). Cytotoxic CD4+ T cells from a sporozoite immunized volunteer recognize the Plasmodiumfalciparum CS protein. Int. Immunol. 3, 997.

Moreno, A., Patarroyo, M. E. (1989). Development of an asexual blood stage malaria vaccine. Blood74, 537-546.

Muller, H. M., Reckman, I., Hollingdale, M. R., Bujard, H., Robson, K. J. H. and Crisant, A. (1993). Thrombospondin related anonymous protein (TRAP) of Plasmodium falciparum binds specifically to sulfated glycoconjugates and to HepG2 hepatoma cells suggesting a role for this molecule in sporozoites invasion of hepatocytes. EA1BO J. 12, 2881-2889.

Muller, P. (1955). "DDT. Das Insektizid Dichlorodiphenyltrichlorathan and seme Bedeutung," pp.14-23, Birkhauser, Basel.

Mulligan, H. W., Russel, P., and Mohan, B. N. (1941). Active immunization of fowls against Plasmodium gallinacium by injection of killed homologous sporozoites. J. Mal. Inst. India 4, 25-34.

Nardin, E. H. and Nussenzweig, R. S. (1993). T cell responses to pre-erythrocytic stages of malaria: Role in protection and vaccine development against pre-erythrocytic stages. Annu. Rev. Immunol. 11, 687-727.

Narum, D. L., and Thomas, A. W. (1994). Defferential localization of full length and processed forms of Pf83? AMA -1 an apical membrane antigen of Plasmodium falciparum merozoites. Mol Biochem. Parasitol. 67, 59-68.

Neugebauer, K. M., Emmett, C. J., Venstrom, K. A., and Reichardt, L. F. (1991). Vitronectin and thrombospondin promote retinal neurite outgrowth: developmental regulation and role ofintegrins. Neuron 6, 345-358.

Noelken, M. E., Wisdom, Jr. B. J., and Hudson, B. G., (1981 ). Estimation of the size of collagenous polypeptides by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Anal. Boichem. 110, 131-136.

Nosten, F., Luxemburger, C., Kyle, D. E., et al. (1996). Randomized double-blind placebo­controlled trial of SPf66 malaria vaccine in children in Northwestern Thailand. Lancet 348, 701-707.

Noya, G. 0., Gabaldon Berti, Y., Alarcon de Noya, B., Borges, R. E., Zerpa, N., Urbaez, J. D., Madonna, A., Garrido, E., Jimnez, M. A, Garcia, P., Reyes, l, Prieto, W., Colmenares, R, Pabon, R, Barraez, T., de Caceres, L. G., Godoy, N., and Sifontes, R. (1993). A population based clinical trial with the SPf66 synthetic Plasmodium falciparum malaria vaccine in Venezuela. J. Infect. Dis. 170, 396-402.

112

Nussenzweig, R. S., and Nussenzweig, V. (1984). Development of sporozoite vaccines. Phi/. Trans. R. Soc. London B 3 07, 117-128.

Nussenzweig, R. S., Vanderberg, J., and Most, H. (1969). Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei: IV. Dose response, specificity and humoral immunity. Mil. Med. 134, 1176-1182.

Nussenzweig, R. S., Vanderberg, J., Most, H., and Orton, C. (1967). Protective immunity induced by the injection of X-irradiated sporozoites of Plasmodium berghei. Nature 216, 160-162.

Nussenzweig, V., and Nussenzweig, R. S. (1985). Circumsporozoite proteins of malaria parasites. Cell42, 401-403.

Nussenzweig, V., and Nussenzweig, R. S. (1989). Rationale for the development of an engineered sporozoite malaria vaccine. Adv. Immunol. 45, 283-334.

Oeuvray, C., Bouharountayoun, H., Filguira, M. C., Grasmasse, H, Tartar, A., and Druilhe, P. (1993). Characterization of Plasmodium falciparum merozoite surface antigen targetted by defense mechanisms developed in immune individuals. C. R Acad. Sci. Ser. III 316, 395-399.

Oeuvray, C., Bouharountayoun, H., Grasmasse, H., Bottius, E., Kaidoh, T., Aikawa, M., Filguira, M. C., Tartar; A, and Druilhe, P. (1994). Merozoite surface protein-3: a malaria protein inducing antibodies that promote Plasmodium Jalciparum killing by cooperation with blood monocytes. Blood 84, 1594-1602.

Oliveira, D. A. Udhayakumar, V., Haynes, J. D., et al. (1996). Genetic conservation of Plasmodiumfalciparum apical merozoite antigen-1 (AMA-1). Mol. Biochem. Parasitol. 76, 333-336.

Orlandi, P. A, Klotz, F. W., Haynes, J. D. (1992). A malaria invasion receptor, the 175-kilodalton erythrocyte binding antigen of Plasmodium Jalciparum recognizes the terminal Neu SAc (alpha2-3) Gal- sequence ofglycophorin A. J. Cell. Bioi. 116,901-909.

Pancake, S. J., Holt, G. D., Mellouk, S., and Hoffman, S. L. (1992). Malaria sporozoites and circumsporozoite protein bind specifically to sulfated glycoconjugates. J. Cell. Bioi. 117,1351-1357.

Pareti, F. 1., Niiya, K., McPherson, J. M., and Ruggeri, Z. M. (1987). Isolation and characterization of two domains of human von Willebrand factor that interact with fibrillar collagen types I and ill. J. Bioi. Chem. 262. 13835-13841.

Patarroyo, G., Franco, L., Amador, R., Murillo, L. A., Rocha, C. L., Rojas, M., and Patarroyo, M. E. (1992). Study of the safety and immunogenicity of the synthetic malaria SPf66vaccineinchildrenaged 1-14years. Vaccine 10,175-178.

Patarroyo, M. E., Amador, R, Clavijo, P., Moreno, A., Guzman, F., Romero, P., Tascon, R., Franco, A., Murillo, L. A., Ponton, G., and Trujillo, G. (1988). A synthetic vaccine

113

protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria. Nature 332, 158-161.

Patarroyo, M. E., Vinasco, J., and Amador, R. (1991). Genetic control of the immune response to a synthetic vaccine against Plasmodium falciparum. Parasite Immunol. 13, 509-516.

Patarroyo, M. E., Romero, P., Torres, M. L., Clavijo, P., Andrew, D., Lozada, D., Sanchez, L., Del Portillo, P., Pinilla, C., Moreno, A, Alegria, A., and Houghten, R. (1987). Protective synthetic peptides against experimental P. jalciparum induced malaria, p. 117-124. In: Vaccines 87. Chanock, R. M., Lerner, L. A., Brown, F., and Ginsberg, H. (eds.). Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.

Paz Soldan, C. E. (1938). "Las tertianas del Condo de Chinchon". Ediciones de la Reform Medica, Lima.

Perkins, M. E, and Rocco, J. (1988). Sialic acid dependent binding of Plasmodium falciparum merozoite surface antigen, Pf200 to human erythrocytes. J. Immunol. 141, 3190-3196.

Perrin, L. H., Merkli, B., Loche, M., Chizzolini, C., Smart, J., and Riehle, R. (1984). Antimalarial immunity to Saimiri monkeys. Immunization with surface components of asexual blood stages. J Exp. Med 160, 441-451.

Perrin, L. H., Ramirez, E., Lambert, P. H., and Miescher, P. A. (1981). Inhibition of P. falciparum growth in human erythrocytes by monoclonal antibodies. Nature 289, 301.

Philips, R. E. eta/. (1986). Q. J Med 58, 305.

Playfair, J. H. L. et a/., ( 1990). Jmmunol. Today 11, 25.

Pongponratn, E., Riganti, M., Punpoowong, B., and Aikawa, M. (1991). Microvascular sequestration of parasitized erythrocytes in human falciparum malaria: a pathological study. Am. J. Trop. Med Hyg. 44, 168-175.

Puri S. K., Maheshwari, R. K., Dutta, G. P., Friedman, R. M., and Dhar, M. M. (1988). Human interferon-gamma protects rhesus monkeys against sporozoite-induced Plasmodium cynomolgi malaria infection. J Interferon. Res. 8, 201-206.

Qu, A., and Leahy, D. J. (1995). Crystal structure of the !-domain from the CD11a/CD18 (LFA-1, alpha L beta 2) integrin. Proc. Nat/. Acad Sci. US A. 92, 10277-10281.

Quakyi, I. A., Otoo, L. N., Pombo, D., Sugars, L. Y., Menon, A., DeGroot, A. S., Johnson, A., Alling, D., Miller, L. H., and Good, M. F. (1989). Differential non-responsiveness in humans of candidate Plasmodium falciparum vaccine antigens. Am. J. trop. Med. Hyg. 41, 125-134.

Reickman, K. H., Davis, D. R., and Hutton, D. C. (1989). P. vivax resistance to chloroquine. Lancet II 1183-1184.

114

Rener, J., Carter, R, Rosenberg, R, Miller, L. H. (1980). Anti gamete monoclonal antibodies synergistically block transmission of malaria by preventing fertilization in the mosquito. Proc. Nat/. Acad. Sci. USA 77, 6797-6799.

Renia, L., Grillot, D., and Marussing, M. et al. (I 993). Effector functions of circumsporozoite peptide-primed CD4+ T cell clones against Plasmodium yoelii liver stages. J. Immunol. 150, 1471-1478.

Renia, L., Mattei, D., Goma, J., et al. (1990). A malaria heat-shock like determinant expressed on the infected hepatocyte surface is the target of antibody dependent cell­mediated cytotoxic mechanisms by nonparenchymalliver cells. Eur. J. Immunol. 20, 1445-1449.

Ridley, R G., Lahm, H. W., Takacs, B., Scaife, and J. G. (1991). Genetic and structural relationships between components of a protective rhoptry antigen complex from Plasmodiumfalciparum. Mol. Biochem. Parasitol. 47, 245-246.

Ridlley, R. G., Takacs, B., Etlinger, H., Scaife, J. G. (1990). A rhoptry antigen of Plasmodiumfalciparum protective in Saimiri monkeys. Parasitology 101, 187-192.

Rieckmann, K. H. (1990). Human immunization with irradiated sporozoites. Bull. WHO 68, 13-16.

Rieckmann, K. H., Beaudoin, R. L., Cassells, J. S., and Sell, K. W. (1979). Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria. Bull. WHO 57(suppl 1), 261-265.

Rieckmann, K. H., Carson, P. E., Beaudoin, R. L., Cassells, J. S., and Sell, K. W. (1974). Sporozoite induced immunity in man against an Ethiopian strain of Plasmodium falciparum. Trans. R. Soc. Trap. Med Hyg. 68, 258-259.

Riggs, P. (1993). Expression and purification of maltose-binding protein fusions: Current Protocols in Molecular Biology. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Sedman, J. G., Smith, J. A., and Struhl, K. (eds.). John Wiley and Sons, New York. pp. 16.6.1-16.6.14.

Riley, E. M., Morris-Jones, S., Blackman, M. J., Greenwood, B. M., and Holder, A. A. (I 993). A longitudinal study of naturally acquired cellular and humoral immune responses to a merozoite surface protein (MSP 1) of Plasmodium falciparum in an area of seasonal malaria transmission. Parasite Immunol. 15, 513-524.

Riley, E.M., Allen, S.J., Wheeler, J.G., Blackman, M.J., Bennet, S., Takacs, B., Schonfeld, H.J., Holder, A.A., and Greenwood, B.M. (1992). Naturally acquired Cellular and humoral immune responses to the major merozoite surface antigen (PfMSP-1) of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunology 14, 321-337.

Roberts, D. J., Craij, A. G., Berendt, A. R., Pinches, R., Nash, G., Marsh, G., and Newbold, C. I. (1992). Rapid switching to multiple antigenic and adhesive phenotypes in malaria. Nature 357, 689-692.

115

Robson, K. J. H., Dolo, A., Hackford, I. R., Doumbo, 0., Richards, M. B., Keita, M. M., Sidibe, T., Bosman, A., Modiano, D., and Crisanti, A. (1998). Natural polymorphism in the thrombospondin-related adhesive protein of Plasmodium falciparum. Am. J. Trap. Med Hyg. 58, 81-89.

Robson, K. J. H., Frevert, U., Reckman, I., Cowan, G., Beier, J., Scragg, I. G., Takehara, K., Bishop, D. H. L., Pradel, G., Sinden, R., Saccheo, S., Muller, H. M. and Crisanti A. (1995). Thrombospondin-related adhesive protein (TRAP) of P. falciparum: expression during sporozoites ontogeny and binding to human hepatocytes. EA1BO J. 14 (16) 3883-3894.

Robson, K. J. H., Hall, J. R. S., Jennings, M. W., Harris, J. J. R., Marsh, K., Newbold, C. I. Tate, V. E. and Weatherall, D. J. (1988). A highly conserved amino acid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite. Nature 335, 79-82.

Robson, K. J. H., Hall, J. R. S., Davies, L. C., Crisanti, A., Hill, A. V. S., and Wellems, T. E. (1990). Polymorphism of the TRAP gene of Plasmodium falciparum. Proc. R Soc. (Land) B. 242, 205-216.

Robson, K. J. H., Naitza, S., Barker, G., Sinden, R. E., and Crisanti, A. (1997). Cloning and expression of thrombospondin-related adhesive protein gene of Plasmodium berghei. Mol. Biochem. Parasitol. 84, 1-12.

Rodriguez, R, Moreno, A., Guzman, F., Calvo, M., and Patarroyo, M. E. (1990). Studies in owl monkeys leading to the development of a synthetic vaccine against the asexual blood stages of Plasmodiumfalciparum. Am. J. Trap. Med. Hyg. 43, 339-354.

Rogers, W. 0., Malik, A., Mallouk, S., Nakamura, K., Rogers, M. D., Szarfman, A., Gordon, D. M., Nusselvi, A. K., Aikawa, M. and Hoffman, S. L. (1992). Characterization of Plasmodium falciparum sporozoite surface protein 2. Proc. Natl. Acad Sci. USA 89, 9176-9180.

Rogers, W. 0., Rogers, M. D., Hedstrom, R. C. and Hoffman, S. L. (1992). Characterization of a gene encoding sporozoite surface protein 2, a protective P. yoelii sporozoite antigen. Mol. Biochem. Parasitol. 53, 45-52.

Rogier, C., and Trape, J. F. (1993). Malaria attacks in children exposed to high transmission: who is protected? Trans. R. Soc. Trap. Med. Hyg. 87, 245-246.

Romero, P. (1992). Malaria vaccines. Curr. Bioi. 4, 432-441.

Ross, R. (1897). Some peculiar pigmented cells found in two mosquitoes fed on malarial blood. Br. Med. J. 2, 1786-1788.

Ross, R. (1898). "Report on the Cultivation of Proteosoma, Iabbe, in Grey Mosquitoes." Gov. Press, Calcutta.

116

Schofield, L. J., Villaquiran, J., Ferreira, A., Schellekens, H., Nussenzweig, R. S., and Nussenzweig, V. (1987). Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature 330, 664-666.

Schofield, L., Bushell, G. R, Cooper, J. A., eta!. (1986). A rhoptry antigen of Plasmodium falciparum contains conserved and variable epitopes recognized by inhibitory monoclonal antibodies. Mol. Biochem. Parasitol. 18, 183-195.

Schulemann,W. (1932). Synthetic antimalarial preparations. Proc. R Soc. Med. 25, 897-905.

Scott, H. H. (1939). "A History of Tropical Medicine." Arnold, London.

Sedegah, M., Hedstrom, R., Hobart, P., et al. (1994). Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein . Proc. Nat. Acad. Sci. USA 91, 9866-9870.

Sedegah, M., Sim, B. K. L., Mason, C. et al. (1992). Naturally acquired CD8+ cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein . J. Immunol. 149, 966-971.

Sergent, E. D., and Parrot, l. (1935). L' immunite, la premunition et la resistance innee. Archives de I' Institut pasteur d' Algerie Xlll, 279.

Sergent, E., and Sergent, E. T. (1956). History of the concept of "relative immunity" or "premunition" correlated to latent infection. Indian J. Malarial. 10, 53-80.

Sharma, P., Bharadwaj, A., Bhasin, V. K., Sailaja, V. N. and Chauhan, V. S. (1996). Antibodies to a conserved-motif peptide sequence of the P. jalciparum thrombospondin­related anonymous protein and circumsporozoite protein recognize a 78-kilodalton protein in the asexual blood stages of the parasite and inhibit merozoite invasion in vitro. Infect. Immun. 64, 2172-2179

Shelton-Inloes, B. B., Titani, K., and Sadler, J. E. (1986). eDNA sequences for human von Willebrand factor reveal five types of repeated domains and five possible protein sequence polymorphisms. Biochemistry 25, 3164-3171.

Siddiqui, W. A., Tam, L. Q., Kramer, K. J., Hui, G. S. N., Case, S. E., Yamaga, K. M. Chang, S. P., Chan, E., B., T., and Kan, S. -C. (1987). Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria. Proc. Nat!. Acad. Sci. USA 84, 3024-3018.

Sieber, K.P., Huber, M., Kaslow, D. C., Banks, S. M., Terri, M., Aikawa, M., and Miller, L. H. (1991). The peritrophic membrane as a barrier: its penetration by Plasmodium gallinaceum and the effect of a monoclonal antibody to ookinetes. Exp. Parasitol. 72, 145-156.

118

Sijwali, P. S., Malhotra, P., Puri, S. K., and Chauhan, V. S. (1997). Cloning and sequence analysis of the thrombospondin-related adhesive protein (TRAP) gene of Plasmodium cynomolgi bastianelli. Mol. Biochem. Parasitol. 90, 371-376.

Sim, B. K. L., Chitnis, C. E., Wasniowska, K., Hadley, T. J., and Miller, L. H. (1994). Receptor and ligand domains for invasion of erythrocytes of Plasmodium falciparum. Science 264, 1941-1944.

Sim, B. K. L., Orlandi, P. A, Haynes, J. D., Klotz, F. W., Carter, J. M., Camus, D., Zegans, M. E., and Chulay, L. D. (1990). Primary structure of 175k Plasmodium falciparum erythrocyte binding antigen and identification of a peptide elicits antibodies that inhibit malaria merozoite invasion. J. Cell. Bioi. 111, 1877-1884.

Sim, B., Toyoshima, T., Haynes, J., and Aikawa, M. (1992). Localization of the 175-kilodalton erythrocyte binding antigen in micronemes of Plasmodium falciparum merozoites. Mol. Biochem. Parasitol. 51, 157-159.

Sinnis, P. and Nussenzweig, V. (1996). Preventing sporozoite invasion of hepatocytes. In: Malaria Vaccine Development: A Multi-Immune Response Approach, Hoffman, S. L. (ed.) Washington, D. C.: American Society for Microbiology, pp. 15-33.

Sinnis, P., Clavijo, P., Fenyo, D., Chait, B. T., Cerami, C., and Nussenzweig, V. (1994). Structural and functional properties of region II plus of the malaria circumsporozoite protein. J. Exp. Med 180, 297-306.

Smith, J.D., Chitnis, C. E., Craig, A. G., Roberts, D. J., Hudson-Taylor, D. E., Peterson, D. S., Pinches, R, Newbold, C. L, and Miller, L. H. (1995). Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes. Cell82, 101-110.

Smythe, J. A, Coppel, R. L., Brown, G. V., Ramasamy, R, Kemp, D. J., and Anders, R. F. (1988). Identification of two integral membrane proteins of Plasmodium falciparum. Proc. Nat/. Acad Sci. USA 85, 5195-5199.

Smythe, J. A, Coppel, R. L., Day, K. P., Martin, R. K., Odula, M. J., Kemp, D. J., and Anders R. F. (1991). Structural diversity in the Plasmodiumfalciparum merozoite surface antigen-2. Proc. Nat!. Acad Sci. USA 88, 1751-1755.

Southern, E. (1975). Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Bioi. 98, 503-517.

Spano, F., Putignani, L., Naitza, S., Puri, C., Wright, S., and Crisanti, A. (1998). Molecular cloning and expression analysis of a Cryptosporidium parvum gene encoding a new member ofthe thrombospondin family. Mol. Biochem. Parasitol. 92, 147-162.

Stoute, J. A, Slaouc, M. D., Heppner, D. G., et al. (1997). A preliminary evaluation of a recombinant CSP vaccine againstP.falciparum malaria. New Eng. J. Med. 336 (2), 86-91.

119

Stowers, A., Taylor,. D., Prescott, N., Cheng, Q., Cooper, J., and Saul, A. (1997). Assessment of the humoral immune response against Plasmodium falciparum rhoptry­associated proteins 1 and 2. Infect. Immun. 65, 2329-2338.

Su, S. D., Sanadi, A. R, Ifon, E., and Davidson, E. A. (1993). A monoclonal antibody capable of blocking the binding of Pf200 (MSA-1) to human erythrocytes and inhibiting the invasion of Plasmodium falciparum merozoites into human erythrocytes. J. Immunol. 151,2309-2317.

Su, X., Heatwole, V. M., Wertheimer, S. P., Guinet, F., Henfeldt, J. A., Peterson, D. S., Ravetch, A. J., and Wellems, T. E. (1995). The diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparum infected erythrocytes. Cell82, 89-100.

Sultan, A. A., Thathy, V., Frevert, U., Robson, K. J., Crisanti, A., Nussenzweig, V., Nussenzweig, R. S., and Menard, R. (1997). TRAP is necessary for gliding motility and infectivity of Plasmodium sporozoites. Cell90, 511-522.

Sun, V. Mosher, D. F., and Rapraeger, A. (1989). Heparin sulfate mediated binding of epithelial cell surface proteoglycan to thrombospondin. J. Biol. Chem. 264, 2885-2889.

Tam, J. P., Clavijo, P., Lu, Y. A., Nussenzweig, V., Nussenzweig, R., and Zavala, F. ( 1990). Incorporation ofT and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria. J. Exp. Med 171, 299-306.

Tanabe, K., Mackay, M., Goman, M., and Scaife, J.G. (1987). Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodiumjalciparum. J. Mol.Biol. 195, 273-287.

Tanner, M., Teuscher, T., and Alonso, P. L. (1995). SPf66-The first malaria vaccine. Parasitol. Today 11, 113.

Targett, G. A. (1998). Malaria-variety is the price of life. Nature 4 (3), 358-360.

Taylor, R. R., Smith, D. B., Robinson, V. J., et al. (1995). Human antibody response to Plasmodiumjalciparum merozoite surface 2 is serogroup specific and predominantly of the immunoglobulin G3 subclass. Inject. Immun. 63, 4382-4388.

Templeton, T. J. and Kaslow, D. C. (1997). Cloning and cross species comparison of the thrombospondin related anonymous protein (TRAP) gene from Plasmodium knowlesi, Plasmodium vivax, and Plasmodium gallinaceum. Mol. Biochem. Parasitol. 84, 13-24.

Thomas, A. W., Carr, D. A, Carter, J. M., and Lyon, A. (1990). Sequence comparison of allelic forms of the Plasmodium falciparum merozoite surface antigen MSA2. Mol. Biochem. Parasitol. 43, 211-220.

Tine, J. A., Lanar, D. E., Smith, D. M., Wellde, B. T., et al. (1996). NYV AC-Pf7: A poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium jalciparum malaria. Infect. Immun. 64, 3833-3844.

120

Tomley, F. M., Clarke, L. E., Kawazoe, U., Dijkema, R., and Kok, J. J. (1991). Sequence of the gene encoding an immunodominant microneme protein of Eimeria tenella. Mol. Biochem. Parasitol. 49, 277-288.

Trager, W., Jensen, J. B. (1970). Human malaria parasites in continuous culture. Science 193, 673-675.

Trape, J. F., Rogier, C., Konate, L., Diagne, N., Bouganali, H, Canque, B., Legros, F., Badji, A., Ndiaye, G., Brahimi, K., Faye, 0., Druilhe, P., and Pereire da Silva, L. (1994). The Dielmo project: a longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in holoendemic area of Senegal. Am. J Trap. Med Hyg. 51, 123-137.

Triglia, T., Stahl, H. D., Crewther, P. E., et al. (1987). The complete sequence of the gene for knob associated histidine-rich protein from P.falciparum. EMBO J. 6, 1413-1419.

Triglia, T., Wellems, T. E., and Kemp, D. J. (1992). Towards a high resolution map of Plasmodiumjalciparum genome. Parasitol. Today. 8, 225-229.

Trottein, F., Triglia, T., and Cowman, A. F. (1995). Molecular cloning of a gene from Plasmodiumfalciparum that codes for a protein sharing motifs found in adhesive molecules from mammals and Plasmodia. Mol. Biochem. Parasitol. 74, 129-141.

Tungpradubkul, S. and Panyinm, S. (1985). Isolation of DNA and total RNA. In: Application of genetic engineering to research on tropical disease pathogens with special reference to Plasmodia (Panyim, S., Wilarat, P. and Yuthavong, Y. eds.) pp. 51-56. WHO Geneva.

Tuszynzki, G. P., Rothman, V. L., Deutch, A. H., Hamilton, B. K., and Eyal, J. (1992). Biological activities of peptides and peptide analogues derived from common sequences present in thrombospondin, properdin and malaria proteins. J. Cell Bioi. 116, 209-217.

Udomsangpetch, R. et al. (1989). J Exp. Med 169, 1835-1840.

Valero, M. V., Amador, R, Galindo, C., Figueroa, J., Bello, M. S., Murillo, L.A., Mora, A. L., Patarroyo, G., Rocha, C. L., Rojas, M., Aponte, J. J., Sarmiento, L. E., Lozada, D., Coronell, C. G., Ortega, N., Rosas, J. E., Alonso, P. L., Patarroyo, M. E. (1993). Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium jalciparum malaria in Colombia. Lancet 341, 705-710.

Valero, M., Amador, R, Aponte, J., Narvaez, a, Galindo, C., Silva, Y., Rosas, J., Guzman, F., and Patarroyo, M. E. Evaluation of SPf66 malaria vaccine during a 22-month follow-up field trial in the Pacific coast of Colombia. Submitted for publication.

Wan, K-L., Carruthers, V. B., Sibley, L. D., and Ajioka, J. W. (1997). Molecular characterization of an expressed sequence tag locus of Toxoplasma gondii encoding the micronemal protein MIC2. Mol. Biochem. Parasitol. 84, 203-214.

Wang, R., Doolan, D. L., Charoenvit, Y., Hedstrom, R. C., Gardner, M. J., Hobart, P., Tine, J., Sedegah, M., Fallarme, V., Sacci, J. B. Jr., Kaur, M., Klinman, D. M., Hoffman, S.

121

L., Weiss, W. R. (1998). Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in nonhuman primates by immunization with a mixture of four Plasmodium falciparum DNA plasmids. Infect. Immun. 66, 4193-4202.

Warrel, D. A., Molyneux, M. E., and Beales, P. F. (1990). Severe and complicated malaria. Second Edition. World Health Organization Malaria action Programme. Trans. R Soc. Trap. Med Hyg. 84 (suppl 2), 1-65.

Weber, J. L., Lyon, J. A, Wolff, R. H., Hall, T., Lowell, G. H., and Chulay, J.D. (1988). Primary structure of Plasmodium falciparum malaria antigen located at the merozoite surface and within the parasitophorous vacuole. J. Bioi. Chem. 263, 11421-11425.

Wedegaertner, P. B., Chu, D. H., Wilson, P. T., Levis, M. J., and Bourne, H. R. (1993). Palmitoylation is required for signaling functions and membrane attachment of Gq alpha and Gs alpha. J. Bioi. Chem. 268,25001-25018.

Weiss, W. R, Sedegah, M., Beaudoin, R. L., Miller, L. H., and Good, M. F. (1988). CD8+ T cells (cytotoxic/suppressor) are required for protection in mice immunized with malaria sporozoites. Proc. Nat!. Acad Sci. USA 85, 573-576.

Wellems, T. E., Walliker. D., Smith, C. L., do Rosario, V. E., Maloy, W. L., Howard, R. J., and Carter, R., McCutchan. T. F. (1987). A histidine-rich protein gene marks a linkage group favored strongly in a genetic cross of Plasmodium falciparum. Cell49 (5), 633-642.

Wernsdorfer, W. H. (1991 ). The development and spread of drug resistant malaria. Parasitol. Today 7, 297-303.

Wiley, D. C., and Skehel, J. J. (1987). The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu. Rev. Biochem. 56, 365-94.

Williamson, K. C., Criscio, M. D., and Kaslow, D. C. (1993). Cloning and expression of the gene for Plasmodium falciparum transmission-blocking target antigen, Pfs230. Mol. Biochem. Parasitol. 58, 355-358.

Wizel, B., Houghten, R. A., Parker, K. C., Coligan, J. E., Church, P., Gordon, D. M., Ballou, W. R., and Hoffman. S. L. (1995). Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodiumfalciparum sporozoite surface protein 2. J. Exp. Med. 182, 1435-1445.

World Health Organization. (1963). "Terminology of Malaria and Malaria Eradication." WHO, Geneva.

Wrightsman, R. A., Dawson, B. D., Fouts, D. L., and Manning, J. E. (1994). Identification of immunodominant epitopes in Trypanosoma cruzi trypomastigote surface antigen-1 protein that mask protective epitopes. J. Immunol. 153, 3148-3154.

Wyler, D. J., Miller, L. H., and Schmidt, L. H. (1977). Spleen function in quartan malaria (due to Plasmodium inui): evidence for both protective and suppressive roles in host defense. J. Infect. Dis. 135, 86.

122

Wyler, D. J., Oster, C. N., and Quinn, T. C. (1979). The role of the spleen in malaria infection. In: Tropical Disease Research Serial No. 1, Role of the Spleen in the immunology ofParasitic Diseases Schwabe & Co., Basel, Switzerland, pp. 183-204.

Yoshida, N., Nussenzweig, R. S., Potocnjak, P., Nussenzweig, V., and Aikawa, M. (1980). Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite. Science 207, 71-73.

Yoshida, N., Potocnjak, P., Nussenzweig, V., Nussenzweig, R. S. (1981). Biosynthesis of Pb44, the protective antigen of sporozoites of Plasmodium berghei. J. Exp. Med. 154, 1225-1236.

Zavala, F., Tam, J. P., Barr, P. J., Romero, P. J., Ley, V., Nussenzweig, R. S., and Nussenzweig, V. (1987). Synthetic peptide vaccine confers protection against murine malaria. J. Exp. Med. 166, 1591-1596.

123